Clinical Trial

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-08
notable Primary completion moved earlier: 2026-09 -> 2026-06-30 2026-07-08
Trial Details
NCT Number NCT05683379
Lead Sponsor REGENXBIO Inc.
Conditions Duchenne Muscular Dystrophy
Enrollment 200 participants
Start Date 2022-12-20
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-07